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Background: Sexual function among women undergoing hemodialysis (HD) is under-studied and there is no
consensus about the effect of sexual dysfunction (SD) on their quality of life (QoL). We aimed to determine the
prevalence of SD and to compare QoL between women undergoing maintenance HD with and without SD.
Methods: We included female end-stage renal disease (ESRD) patients undergoing HD during June 2011 in the
only renal unit in the north of Ceará state, northeastern Brazil. The criteria for inclusion were age between 18 and
55, at least three months on dialysis and being sexually active. Women using antidepressant medication were
excluded. We used the Female Sexual Function Index (FSFI), which evaluates six domains of sexual function,
including desire, arousal, lubrication, orgasm, satisfaction and pain. The patients were classified as presenting SD if
the total FSFI score was less than 26. For QoL evaluation, we used the validated Brazilian version of SF-36. This is a
widely used 36-item questionnaire covering eight dimensions of QoL. Demographic data, time on dialysis,
underlying etiology of ESRD, and laboratory measures were assessed in unit records.
Results: Of a total of 58 women, 46 (79.3%) presented SD. There were lower scores related to physical functioning
(48.2 vs. 71.2; p = 0.007), bodily pain (45 vs. 67.5; p = 0.010), vitality (52.1 vs. 69.1; p = 0.026) and social functioning
(57.2 vs. 76.1; p = 0.034) among women with SD compared to women without SD. Physical functioning and
role-physical presented positive linear correlation with FSFI scores, respectively, r = 0.322 (p = 0.013) and r = 0.345
(p = 0.007).
Conclusion: The prevalence of SD among women on HD is very high, reaching nearly 80%. Women on HD with
SD had worse QoL, especially physical aspects of QoL, when compared to women without SD. Therefore,
approaches aiming to improve QoL among women undergoing HD should be considered.
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End-stage renal disease (ESRD) is the stage reached by
chronic renal diseases in which kidneys function is irre-
versibly lower than 15% of normal function. ESRD is
fatal unless some kind of renal replacement is offered
(dialysis or kidney transplantation). Worldwide there is a
shortage of organs to transplant and new cases of ESRD
are increasing rapidly, making hemodialysis (HD) the* Correspondence: prsantos@fortalnet.com.br
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reproduction in any medium, provided the ormost used form of renal replacement [1]. There are
more than one million patients in the world undergoing
maintenance dialysis and nearly 90,000 in Brazil [2].
ESRD strongly affects sexual function, mainly because
of endocrine abnormalities [3]. Sexual dysfunction (SD)
is well studied among men mainly concerning erectile
dysfunction. Erectile dysfunction is highly prevalent
among ESRD men [4]. In our experience, erectile dys-
function is present in half of young men undergoing dia-
lysis and it generally compromises mental health [5].
However, SD among women is less studied. For instance,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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4,389 men but only two studies covering 306 women [6].
Based on the few studies that have been conducted, it
seems that SD is also common among women on HD
[6]. However, based on a Brazilian study [7] and another
from the United States [8], this apparently does not
affect their quality of life (QoL), in contrast to many
findings indicating that among male HD patients, the
mental aspect of QoL is greatly affected by erectile dys-
function [5]. Do women under dialysis perceive SD in a
way that their QoL is not affected? Is there a different
pattern concerning QoL in men and women with SD on
dialysis? These questions intrigued us, so we aimed to
determine the prevalence of SD and to compare QoL be-




We included ESRD women undergoing HD during June
2011 in the only renal unit in the north of Ceará state,
northeastern Brazil. The criteria for inclusion were age
between 18 and 55, at least three months on dialysis and
being sexually active. The 55-year age limit was based
on a Brazilian study that found no sexual activity among
female ESRD on dialysis older than 60 years [7]. Women
using antidepressant medication were also excluded.
Fifty-eight women were included from a total of 79.
Among the patients excluded there were 10 with less
than three months on therapy, 7 without sexual activity,
3 who refused to participate and 1 with cognitive impair-
ment and another using antidepressant medication. All
patients were undergoing conventional HD (three ses-
sions of four hours per week) with polysulfone dialyzers
(maximum number of reuses = 12). The study protocol
and informed consent were approved by the ethics com-
mittee of Vale do Acaraú University, with which the hos-
pital is associated.
Evaluation of sexual dysfunction
We used the Female Sexual Function Index (FSFI) as
validated in Brazil by Pacagnella et al. [9]. This is a 19-
item questionnaire that evaluates six domains of sexual
function including desire, arousal, lubrication, orgasm,
satisfaction and pain. The overall score is the sum of the
scores for each item multiplied by a domain factor. The
minimum and maximum scores are respectively 2 and
36. Women with a score under 26 were classified as pre-
senting sexual dysfunction. This cut-off was the same
figure validated by other researchers [10].
Measurement of quality of life
We used the validated Brazilian version of the Medical
Outcomes Study 36-Item Short Form Health Questionnaire(SF-36) to measure the QoL level [11]. This is a well-
validated 36-item questionnaire covering eight dimensions
of QoL: physical functioning, role-physical, bodily pain,
general health, vitality, social functioning, role-emotional
and mental health. SF-36 generates scores from 0 (worst)
to 100 (best) for each of the eight dimensions.
Patient data
The demographic data, time on dialysis and underlying
etiology of ESRD were assessed in unit records. The
underlying kidney disease was classified by clinical cri-
teria and not by histopathology. Classification of eco-
nomic class was according to the criteria of the Brazilian
Association of Research Institutes [12]. This validated
instrument is used in marketing surveys and population
censuses and grades economic class into five groups: A
(highest economic class) through E (lowest). Its criteria
include educational level of the head of household and
ownership of household appliances.
The laboratory results were those routinely measured
in HD patients: creatinine and albumin (markers of nu-
tritional status and inflammation activity), hemoglobin
(level of anemia, target among HD patients = 11-12 g/dl),
calcium and phosphorus (calcium and phosphorus prod-
uct above 55 mg2/dl2 indicates risk of tissue deposition)
and Kt/V (index of the dose of dialysis delivered, target ≥
1.2). Kt/V was estimated by using a second-generation
Daugirdas formula [13].
Statistical analyses
The Kolmogorov-Smirnov test was used to test for nor-
mal distribution of the continuous variables. Continuous
variables with normal distribution are shown as mean ±
SD, and if without normal distribution as median. Cat-
egorical variables are shown as percentages. Compari-
sons regarding continuous variables were performed by
the Student-t and Mann-Whitney tests, respectively for
continuous variables with normal and without normal
distribution. Comparisons regarding categorical variables
were performed by the Fisher test. Specifically, compari-
son between SF-36 scores according to SD was carried
out by analysis of variance with covariates (ANCOVA),
adjusted for age, economic class, time on dialysis, pres-
ence of diabetes, hemoglobin, albumin and Kt/V (which
are traditional variables used in adjustments among HD
samples). Correlation coefficients between SF-36 and
FSFI scores were calculated by the Pearson test. P < 0.05
was considered significant. All the statistical analyses
were performed using the Statistical Package for Social
Sciences (SPSS, version 13.0 for Windows) [14].
Results
Mean age of the sample was 38.9 ± 10.8 years. Partici-
pants were mainly from economic classes C (41.1%) and
Table 2 Comparison of sexual function domain scores










Desirea 2.5 ± 1.1 2.2 ± 1.0 3.8 ± 0.7 <0.001
Arousalb 1.9 ± 1.8 1.2 ± 1.1 4.4 ± 0.3 <0.001
Lubrificationb 2.2 ± 2.1 1.5 ± 1.8 4.9 ± 1.0 <0.001
Orgasmb 2.2 ± 2.1 1.5 ± 1.8 4.9 ± 0.7 <0.001
Satisfactionc 3.1 ± 2.1 2.4 ± 1.8 5.6 ± 0.4 <0.001
Painb 2.3 ± 2.2 1.6 ± 1.8 5.0 ± 0.9 <0.001
Data are means ± standard deviations.
aRange of scores 1.2-6.
bRange of scores 0-6.
cRange of scores 0.8-6.
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nephrosclerosis (20.7%) were the main causes of ESRD.
Women were undergoing HD for a median of 36 months.
Regarding laboratory measurements, mean values were:
8.3 ± 1.8 mg/dl for creatinine, 9.5 ± 2.0 g/dl for hemo-
globin, 3.8 ± 0.3 g/dl for albumin, 46.8 ± 14.6 for calcium-
phosphorus products, and 1.9 ± 0.3 for Kt/V index
(Table 1).
From a total of 58 women, 46 (79.3%) presented sexual
dysfunction. The median of FSFI scores was 15.4 (min =
2; max = 36) for the total sample, 6.8 for women with
SD and 28.5 for those without SD. The scores according
to each domain of sexual function are shown in Table 2.
There were no differences regarding sample characteris-
tics between women with and without SD, as shown in
Table 1. There were lower scores related to physical
functioning (48.2 vs. 71.2; p = 0.007), bodily pain (45 vs.
67.5; p = 0.010), vitality (52.1 vs. 69.1; p = 0.026) and so-
cial functioning (57.2 vs. 76.1; p = 0.034) among women
with SD when compared to women without dysfunctionTable 1 Comparison of sample characteristics between










Age 38.9 ± 10.8 39.4 ± 11.3 35.9 ± 7.6 0.511
Economic class
B 3 (5.2) 1 (2.4) 2 (16.6) 0.678
C 24 (41.4) 20 (43.4) 4 (33.3)
D 26 (44.8) 21 (45.6) 5 (41.8)
E 5 (8.6) 4 (8.6) 1 (8.3)
Time on dialysis
(months)
36 37.5 44 0.184
Underlying kidney disease
Glomerulonephritis 33 (56.9) 25 (54.6) 8 (66.6) 0.834
Hypertensive
nephrosclerosis
12 (20.7) 10 (21.7) 2 (16.8)
Diabetic nephropathy 5 (8.6) 4 (8.6) 1 (8.3)
Lupus nephritis 2 (3.5) 2 (4.3) 0
Obstructive uropathy 2 (3.5) 2 (4.3) 0
Polycystic kidney 1 (1.7) 0 1 (8.3)
Undetermined 3 (5.1) 3 (6.5) 0
Laboratory
Creatinine (mg/dl) 8.3 ± 1.8 8.3 ± 1.8 8.5 ± 1.8 0.708
Hemoglobin (g/dl) 9.5 ± 2.0 9.4 ± 2.0 9.7 ± 1.7 0.650
Albumin (g/dl) 3.8 ± 0.3 3.8 ± 0.3 3.8 ± 0.4 0.951
Calcium-phosphorus
product
46.8 ± 14.6 46.2 ± 14.9 49.3 ± 13.6 0.513
(mg2/dl2)
Kt/V 1.9 ± 0.3 1.9 ± 0.3 1.9 ± 0.4 0.966
Data are means ± standard deviations and percentages (%) in parentheses.
Time on dialysis was not normally distributed and is shown as median.(Table 3). Physical functioning and role-physical pre-
sented positive linear correlation with FSFI scores, re-
spectively of r = 0.322 (p = 0.013) and r = 0.345 (p = 0.007)
(Table 4).
Discussion
The SD prevalence of 79.3% is near the 80% found by
Seethala et al. [8] and is within the range of 30 to 80%
found in the overall literature [6]. The hypothesis that
women with SD do not have low QoL was rejected, un-
like found by other authors [7,8]. The results from our
sample indicate that physical dimensions of QoL are
lowered, mainly the physical aspects, based on the fact
that physical functioning and bodily pain were the most
affected dimensions among the women studied. Add-
itionally, reinforcing the association between physical
dimensions of QoL and SD, the only two dimensions
linearly and positively correlated to FSFI scores were
physical functioning and role-physical. The positive cor-
relation between role-physical and FSFI scores is corro-
borated by a recent study [15]. This same study also
found no correlation between mental health and SD
among women on dialysis, in line with our results [15].
This is a completely different result from that we
found in a sample of men with erectile dysfunction from
the same renal unit in a previous study [5]. In that study,
men undergoing hemodialysis with erectile dysfunction
presented lower mental health, with no impairment of
physical dimensions of QoL [5]. It is beyond the scope
of the present study to clarify the mechanisms involved
in the association between SD and physical dimensions
of QoL among women. But we can suggest that physical
aspects of QoL are largely dependent on the clinical
physical status of patients, as in several other illnesses
[16]. Unfortunately, the two studies [7,8] that found no
correlation of SD with QoL among women on HD used
a different tool to measure QoL, making it impossible to
compare the present result on female patients’ physical
QoL with the findings of those studies.









Physical functioning 48.2 ± 26.3 71.2 ± 21.7 0.007
Role-physical 20.6 ± 31.3 37.5 ± 34.5 0.054
Bodily pain 45.0 ± 27.1 67.5 ± 22.9 0.010
General health 42.0 ± 23.8 46.0 ± 21.9 0.606
Vitality 52.1 ± 23.3 69.1 ± 22.2 0.027
Social functioning 57.2 ± 27.6 76.1 ± 23.4 0.034
Role-emotional 28.0 ± 37.0 52.8 ± 48.1 0.057
Mental health 56.3 ± 23.3 70.6 ± 19.5 0.056
Data are means ± standard deviations.
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any conclusions about the direction of the relationship:
whether low physical QoL causes SD or SD causes low
Qol. In any event, based on these preliminary findings it
is advisable to consider SD as a target when planning
interventions to improve QoL among women on dialy-
sis. Unfortunately, there are few studies about treatment
for SD among women on dialysis. The Cochrane data-
base of systematic reviews contains 16 studies on inter-
ventions for treating SD in patients with chronic kidney
disease, but only one of these covers women [17]. Pos-
sible approaches to female SD are hormone replacement
(estrogen/progesterone and androgens), correction of
anemia, adequate dialysis delivery and screening for de-
pression [3]. In our sample, dialysis delivery reached the
target (mean Kt/V of 1.9, target > 1.2), but anemia con-
trol must be improved (mean hemoglobin of 9.5 g/dl,
target of 10-11 g/dl). Additionally, kidney transplant-
ation must be encouraged because there are findings of
improvement of SD after transplantation [18-20]. How-
ever, there are also divergent results showing SD of
93.4% among women receiving transplants [21].
We must emphasize that our sample is characteristic
of a low-income area: more than half of the womenTable 4 Correlation coefficients between SF-36 and FSFI
scores
SF-36 dimensions FSFI scores
R P
Physical functioning 0.322 0.013
Role-physical 0.345 0.007
Bodily pain 0.112 0.402
General health 0.113 0.398
Vitality 0.172 0.195
Social functioning 0.212 0.110
Role-emotional 0.215 0.105
Mental health 0.188 0.157belong to the lower economic classes, with few diabetics.
Besides the impossibility of extrapolating our results to
women in more developed regions, there are several
other limitations. First, it is small sample from a single
renal unit. Second, we did not evaluate medications used
that could interfere with SD (except data on antidepres-
sant medication), although a study reported no correl-
ation between degree of sexual dysfunction and
medication [22]. Third, we did not distinguish the mari-
tal status of the women, while Seethala [8] did address
this issue, finding no correlation between SD and the
marital status.
Conclusions
For clinical practice, our finding of high prevalence of
SD and its association with lower QoL points to the
need for routine screening of sexual function among
women undergoing HD, aiming to put into practice pos-
sible approaches to SD in an attempt to improve
patients’ QoL, which is the main outcome of HD treat-
ment. Future research should investigate larger samples,
first to confirm our rejection of the hypothesis that QoL
level is the same between women with and without SD,
as found by others, and, second to determine risk factors
for SD.
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